SidaGhanaV1, Main, Exploration, bibRecord, 000466

Long-term effectiveness of first-line non-nucleoside reverse transcriptase inhibitor (NNRTI)-based antiretroviral therapy in Ghana.

Identifieur interne : 000466 ( Main/Exploration ); précédent : 000465; suivant : 000467

Long-term effectiveness of first-line non-nucleoside reverse transcriptase inhibitor (NNRTI)-based antiretroviral therapy in Ghana.

Auteurs : Fred S. Sarfo [Ghana] ; Maame Anima Sarfo ; Adetayo Kasim ; Richard Phillips ; Mark Booth ; David Chadwick

Source :

The Journal of antimicrobial chemotherapy [ 1460-2091 ] ; 2014.

RBID : pubmed:24003181

Descripteurs français

KwdFr :
- Abstention thérapeutique, Adulte, Adulte d'âge moyen, Analyse de survie, Antirétroviraux (pharmacologie), Antirétroviraux (usage thérapeutique), Benzoxazines (effets indésirables), Benzoxazines (pharmacologie), Benzoxazines (usage thérapeutique), Charge virale, Femelle, Ghana, Humains, Infections à VIH (traitement médicamenteux), Inhibiteurs de la transcriptase inverse (effets indésirables), Inhibiteurs de la transcriptase inverse (pharmacologie), Inhibiteurs de la transcriptase inverse (usage thérapeutique), Mâle, Numération des lymphocytes CD4, Névirapine (effets indésirables), Névirapine (pharmacologie), Névirapine (usage thérapeutique), Résultat thérapeutique, Thérapie antirétrovirale hautement active (), Études rétrospectives.
MESH :
- effets indésirables : Benzoxazines, Inhibiteurs de la transcriptase inverse, Névirapine.
- pharmacologie : Antirétroviraux, Benzoxazines, Inhibiteurs de la transcriptase inverse, Névirapine.
- traitement médicamenteux : Infections à VIH.
- usage thérapeutique : Antirétroviraux, Benzoxazines, Inhibiteurs de la transcriptase inverse, Névirapine.
- Abstention thérapeutique, Adulte, Adulte d'âge moyen, Analyse de survie, Charge virale, Femelle, Ghana, Humains, Mâle, Numération des lymphocytes CD4, Résultat thérapeutique, Thérapie antirétrovirale hautement active, Études rétrospectives.
Wicri :
- geographic : Ghana.

English descriptors

KwdEn :
- Adult, Anti-Retroviral Agents (pharmacology), Anti-Retroviral Agents (therapeutic use), Antiretroviral Therapy, Highly Active (methods), Benzoxazines (adverse effects), Benzoxazines (pharmacology), Benzoxazines (therapeutic use), CD4 Lymphocyte Count, Female, Ghana, HIV Infections (drug therapy), Humans, Male, Middle Aged, Nevirapine (adverse effects), Nevirapine (pharmacology), Nevirapine (therapeutic use), Retrospective Studies, Reverse Transcriptase Inhibitors (adverse effects), Reverse Transcriptase Inhibitors (pharmacology), Reverse Transcriptase Inhibitors (therapeutic use), Survival Analysis, Treatment Outcome, Viral Load, Withholding Treatment.
MESH :
- chemical , adverse effects : Benzoxazines, Nevirapine, Reverse Transcriptase Inhibitors.
- chemical , pharmacology : Anti-Retroviral Agents, Benzoxazines, Nevirapine, Reverse Transcriptase Inhibitors.
- chemical , therapeutic use : Anti-Retroviral Agents, Benzoxazines, Nevirapine, Reverse Transcriptase Inhibitors.
- geographic : Ghana.
- drug therapy : HIV Infections.
- methods : Antiretroviral Therapy, Highly Active.
- Adult, CD4 Lymphocyte Count, Female, Humans, Male, Middle Aged, Retrospective Studies, Survival Analysis, Treatment Outcome, Viral Load, Withholding Treatment.

Abstract

Information on the long-term effectiveness and tolerability of efavirenz- or nevirapine-based antiretroviral therapy (ART) in Africa is lacking. The primary objective of this retrospective observational study was to compare the long-term clinical and immunological outcomes of efavirenz- versus nevirapine-based first-line ART in a large government clinic in Ghana.

DOI: 10.1093/jac/dkt336
PubMed: 24003181

Affiliations:

Ghana

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Long-term effectiveness of first-line non-nucleoside reverse transcriptase inhibitor (NNRTI)-based antiretroviral therapy in Ghana.</title>
<author><name sortKey="Sarfo, Fred S" sort="Sarfo, Fred S" uniqKey="Sarfo F" first="Fred S" last="Sarfo">Fred S. Sarfo</name>
<affiliation wicri:level="1"><nlm:affiliation>Komfo Anokye Teaching Hospital, Kumasi, Ghana.</nlm:affiliation>
<country xml:lang="fr">Ghana</country>
<wicri:regionArea>Komfo Anokye Teaching Hospital, Kumasi</wicri:regionArea>
<wicri:noRegion>Kumasi</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Sarfo, Maame Anima" sort="Sarfo, Maame Anima" uniqKey="Sarfo M" first="Maame Anima" last="Sarfo">Maame Anima Sarfo</name>
</author>
<author><name sortKey="Kasim, Adetayo" sort="Kasim, Adetayo" uniqKey="Kasim A" first="Adetayo" last="Kasim">Adetayo Kasim</name>
</author>
<author><name sortKey="Phillips, Richard" sort="Phillips, Richard" uniqKey="Phillips R" first="Richard" last="Phillips">Richard Phillips</name>
</author>
<author><name sortKey="Booth, Mark" sort="Booth, Mark" uniqKey="Booth M" first="Mark" last="Booth">Mark Booth</name>
</author>
<author><name sortKey="Chadwick, David" sort="Chadwick, David" uniqKey="Chadwick D" first="David" last="Chadwick">David Chadwick</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2014">2014</date>
<idno type="RBID">pubmed:24003181</idno>
<idno type="pmid">24003181</idno>
<idno type="doi">10.1093/jac/dkt336</idno>
<idno type="wicri:Area/PubMed/Corpus">000211</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000211</idno>
<idno type="wicri:Area/PubMed/Curation">000211</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000211</idno>
<idno type="wicri:Area/PubMed/Checkpoint">000211</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000211</idno>
<idno type="wicri:Area/Ncbi/Merge">000594</idno>
<idno type="wicri:Area/Ncbi/Curation">000594</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">000594</idno>
<idno type="wicri:Area/Main/Merge">000466</idno>
<idno type="wicri:Area/Main/Curation">000466</idno>
<idno type="wicri:Area/Main/Exploration">000466</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Long-term effectiveness of first-line non-nucleoside reverse transcriptase inhibitor (NNRTI)-based antiretroviral therapy in Ghana.</title>
<author><name sortKey="Sarfo, Fred S" sort="Sarfo, Fred S" uniqKey="Sarfo F" first="Fred S" last="Sarfo">Fred S. Sarfo</name>
<affiliation wicri:level="1"><nlm:affiliation>Komfo Anokye Teaching Hospital, Kumasi, Ghana.</nlm:affiliation>
<country xml:lang="fr">Ghana</country>
<wicri:regionArea>Komfo Anokye Teaching Hospital, Kumasi</wicri:regionArea>
<wicri:noRegion>Kumasi</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Sarfo, Maame Anima" sort="Sarfo, Maame Anima" uniqKey="Sarfo M" first="Maame Anima" last="Sarfo">Maame Anima Sarfo</name>
</author>
<author><name sortKey="Kasim, Adetayo" sort="Kasim, Adetayo" uniqKey="Kasim A" first="Adetayo" last="Kasim">Adetayo Kasim</name>
</author>
<author><name sortKey="Phillips, Richard" sort="Phillips, Richard" uniqKey="Phillips R" first="Richard" last="Phillips">Richard Phillips</name>
</author>
<author><name sortKey="Booth, Mark" sort="Booth, Mark" uniqKey="Booth M" first="Mark" last="Booth">Mark Booth</name>
</author>
<author><name sortKey="Chadwick, David" sort="Chadwick, David" uniqKey="Chadwick D" first="David" last="Chadwick">David Chadwick</name>
</author>
</analytic>
<series><title level="j">The Journal of antimicrobial chemotherapy</title>
<idno type="eISSN">1460-2091</idno>
<imprint><date when="2014" type="published">2014</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adult</term>
<term>Anti-Retroviral Agents (pharmacology)</term>
<term>Anti-Retroviral Agents (therapeutic use)</term>
<term>Antiretroviral Therapy, Highly Active (methods)</term>
<term>Benzoxazines (adverse effects)</term>
<term>Benzoxazines (pharmacology)</term>
<term>Benzoxazines (therapeutic use)</term>
<term>CD4 Lymphocyte Count</term>
<term>Female</term>
<term>Ghana</term>
<term>HIV Infections (drug therapy)</term>
<term>Humans</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Nevirapine (adverse effects)</term>
<term>Nevirapine (pharmacology)</term>
<term>Nevirapine (therapeutic use)</term>
<term>Retrospective Studies</term>
<term>Reverse Transcriptase Inhibitors (adverse effects)</term>
<term>Reverse Transcriptase Inhibitors (pharmacology)</term>
<term>Reverse Transcriptase Inhibitors (therapeutic use)</term>
<term>Survival Analysis</term>
<term>Treatment Outcome</term>
<term>Viral Load</term>
<term>Withholding Treatment</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Abstention thérapeutique</term>
<term>Adulte</term>
<term>Adulte d'âge moyen</term>
<term>Analyse de survie</term>
<term>Antirétroviraux (pharmacologie)</term>
<term>Antirétroviraux (usage thérapeutique)</term>
<term>Benzoxazines (effets indésirables)</term>
<term>Benzoxazines (pharmacologie)</term>
<term>Benzoxazines (usage thérapeutique)</term>
<term>Charge virale</term>
<term>Femelle</term>
<term>Ghana</term>
<term>Humains</term>
<term>Infections à VIH (traitement médicamenteux)</term>
<term>Inhibiteurs de la transcriptase inverse (effets indésirables)</term>
<term>Inhibiteurs de la transcriptase inverse (pharmacologie)</term>
<term>Inhibiteurs de la transcriptase inverse (usage thérapeutique)</term>
<term>Mâle</term>
<term>Numération des lymphocytes CD4</term>
<term>Névirapine (effets indésirables)</term>
<term>Névirapine (pharmacologie)</term>
<term>Névirapine (usage thérapeutique)</term>
<term>Résultat thérapeutique</term>
<term>Thérapie antirétrovirale hautement active ()</term>
<term>Études rétrospectives</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="adverse effects" xml:lang="en"><term>Benzoxazines</term>
<term>Nevirapine</term>
<term>Reverse Transcriptase Inhibitors</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="pharmacology" xml:lang="en"><term>Anti-Retroviral Agents</term>
<term>Benzoxazines</term>
<term>Nevirapine</term>
<term>Reverse Transcriptase Inhibitors</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Anti-Retroviral Agents</term>
<term>Benzoxazines</term>
<term>Nevirapine</term>
<term>Reverse Transcriptase Inhibitors</term>
</keywords>
<keywords scheme="MESH" type="geographic" xml:lang="en"><term>Ghana</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>HIV Infections</term>
</keywords>
<keywords scheme="MESH" qualifier="effets indésirables" xml:lang="fr"><term>Benzoxazines</term>
<term>Inhibiteurs de la transcriptase inverse</term>
<term>Névirapine</term>
</keywords>
<keywords scheme="MESH" qualifier="methods" xml:lang="en"><term>Antiretroviral Therapy, Highly Active</term>
</keywords>
<keywords scheme="MESH" qualifier="pharmacologie" xml:lang="fr"><term>Antirétroviraux</term>
<term>Benzoxazines</term>
<term>Inhibiteurs de la transcriptase inverse</term>
<term>Névirapine</term>
</keywords>
<keywords scheme="MESH" qualifier="traitement médicamenteux" xml:lang="fr"><term>Infections à VIH</term>
</keywords>
<keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr"><term>Antirétroviraux</term>
<term>Benzoxazines</term>
<term>Inhibiteurs de la transcriptase inverse</term>
<term>Névirapine</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Adult</term>
<term>CD4 Lymphocyte Count</term>
<term>Female</term>
<term>Humans</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Retrospective Studies</term>
<term>Survival Analysis</term>
<term>Treatment Outcome</term>
<term>Viral Load</term>
<term>Withholding Treatment</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Abstention thérapeutique</term>
<term>Adulte</term>
<term>Adulte d'âge moyen</term>
<term>Analyse de survie</term>
<term>Charge virale</term>
<term>Femelle</term>
<term>Ghana</term>
<term>Humains</term>
<term>Mâle</term>
<term>Numération des lymphocytes CD4</term>
<term>Résultat thérapeutique</term>
<term>Thérapie antirétrovirale hautement active</term>
<term>Études rétrospectives</term>
</keywords>
<keywords scheme="Wicri" type="geographic" xml:lang="fr"><term>Ghana</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Information on the long-term effectiveness and tolerability of efavirenz- or nevirapine-based antiretroviral therapy (ART) in Africa is lacking. The primary objective of this retrospective observational study was to compare the long-term clinical and immunological outcomes of efavirenz- versus nevirapine-based first-line ART in a large government clinic in Ghana.</div>
</front>
</TEI>
<affiliations><list><country><li>Ghana</li>
</country>
</list>
<tree><noCountry><name sortKey="Booth, Mark" sort="Booth, Mark" uniqKey="Booth M" first="Mark" last="Booth">Mark Booth</name>
<name sortKey="Chadwick, David" sort="Chadwick, David" uniqKey="Chadwick D" first="David" last="Chadwick">David Chadwick</name>
<name sortKey="Kasim, Adetayo" sort="Kasim, Adetayo" uniqKey="Kasim A" first="Adetayo" last="Kasim">Adetayo Kasim</name>
<name sortKey="Phillips, Richard" sort="Phillips, Richard" uniqKey="Phillips R" first="Richard" last="Phillips">Richard Phillips</name>
<name sortKey="Sarfo, Maame Anima" sort="Sarfo, Maame Anima" uniqKey="Sarfo M" first="Maame Anima" last="Sarfo">Maame Anima Sarfo</name>
</noCountry>
<country name="Ghana"><noRegion><name sortKey="Sarfo, Fred S" sort="Sarfo, Fred S" uniqKey="Sarfo F" first="Fred S" last="Sarfo">Fred S. Sarfo</name>
</noRegion>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/SidaGhanaV1/Data/Main/Exploration

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000466 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000466 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    SidaGhanaV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     pubmed:24003181
   |texte=   Long-term effectiveness of first-line non-nucleoside reverse transcriptase inhibitor (NNRTI)-based antiretroviral therapy in Ghana.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i   -Sk "pubmed:24003181" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd   \
       | NlmPubMed2Wicri -a SidaGhanaV1

This area was generated with Dilib version V0.6.31.
Data generation: Tue Nov 7 18:07:38 2017. Site generation: Tue Mar 5 15:01:57 2024

Le SIDA au Ghana (serveur d'exploration)

Long-term effectiveness of first-line non-nucleoside reverse transcriptase inhibitor (NNRTI)-based antiretroviral therapy in Ghana.

Long-term effectiveness of first-line non-nucleoside reverse transcriptase inhibitor (NNRTI)-based antiretroviral therapy in Ghana.

Source :

Descripteurs français

English descriptors

Abstract

Links toward previous steps (curation, corpus...)

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

Pour générer des pages wiki

	Le SIDA au Ghana (serveur d'exploration)
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.